Cargando…
Eltrombopag increases the hematopoietic supporting ability of mesenchymal stem/stromal cells
BACKGROUND: Eltrombopag (EP) is a small molecule that acts directly on hematopoietic stem cells (HSCs) and megakaryocytes to stimulate the hematopoietic process. Mesenchymal stem/stromal cells (MSCs) are key hematopoietic niche regulators. OBJECTIVES: We aimed to determine whether EP has any effect...
Autores principales: | Muntión, Sandra, Preciado, Silvia, Sánchez-Luis, Elena, Corchete, Luis, Díez-Campelo, María, Osugui, Lika, Martí-Chillón, Gerardo-Javier, Vidriales, María-Belén, Navarro-Bailón, Almudena, De Las Rivas, Javier, Sánchez-Guijo, Fermín |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806379/ https://www.ncbi.nlm.nih.gov/pubmed/36601635 http://dx.doi.org/10.1177/20406207221142137 |
Ejemplares similares
-
Therapeutic potential of mesenchymal stromal/stem cells in critical‐care patients with systemic inflammatory response syndrome
por: Martí‐Chillón, Gerardo‐Javier, et al.
Publicado: (2023) -
Co-administration of human MSC overexpressing HIF-1α increases human CD34(+) cell engraftment in vivo
por: Preciado, Silvia, et al.
Publicado: (2021) -
The Incorporation of Extracellular Vesicles from Mesenchymal Stromal Cells Into CD34(+) Cells Increases Their Clonogenic Capacity and Bone Marrow Lodging Ability
por: Preciado, Silvia, et al.
Publicado: (2019) -
Microvesicles from Mesenchymal Stromal Cells Are Involved in HPC-Microenvironment Crosstalk in Myelodysplastic Patients
por: Muntión, Sandra, et al.
Publicado: (2016) -
MSCs from polytrauma patients: preliminary comparative study with MSCs from elective-surgery patients
por: López, Raúl, et al.
Publicado: (2021)